August 22, 2025

Research Roundup: Optical Innovation, Volatile Algorithms, and Better Liquid Biopsies

What does the future of bladder cancer monitoring look like? Recent research offers some clues...

The Pathologist

August 22, 2025

Mapping Out Standards for Newborn Sepsis Diagnostics

Target product profile highlights priority settings and performance needs for newborn diagnostic tests

The Pathologist

August 20, 2025

Metagenomics Hits UK Clinical Practice

UK hospitals are diagnosing tricky infection cases using metagenomics, thanks to the award-winning work of one London team

The Pathologist

August 19, 2025

AAP Vaccine Recommendations Veer From ACIP

AAP released 2025 evidence-based US childhood and adolescent immunization schedule with updates for RSV, influenza, COVID-19, HPV, and meningococcal vaccines.

Conexiant

August 19, 2025

H5N1 and the Diagnostic Frontline

Bobbi S. Pritt outlines how CAP’s 2025 proficiency testing program will help diagnostic labs stay ahead of evolving respiratory threats

The Pathologist

August 18, 2025

Societies Issue Joint Updates to Hypertension Guidelines

A central update is the recommendation for use of the PREVENT calculator to help determine risk.

Conexiant

August 18, 2025

Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS

A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center offers a promising treatment option for patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).

Roswell Park Comprehensive Cancer Center

August 18, 2025

Medicare Advantage Audits Are Expanding

Continuing its efforts to reduce fraud, waste, and abuse in Medicare, the Centers for Medicare & Medicaid Services (CMS) has announced plans to significantly enhance Risk Adjustment Data Validatio...

The ASCO Post

August 18, 2025

New Data Show Nearly 50% of All Cancer Deaths Worldwide Are Attributable to Modifiable Risk Factors

New reporting in The Cancer Atlas, Fourth Edition, showed that an estimated 50% of all cancer deaths worldwide are attributed to modifiable risk factors, including tobacco and alcohol use, infections,...

The ASCO Post